NASDAQ Biotechnology Total Retu XNBI Indice
4501.69 USD
{{ price }}
-2.144341%
{{change_pct}}%
PAYS
États-Unis
Marché
Nasdaq GIDS
Plus Haut - Plus Bas [24H]
4479.13
-
4578.05 USD
Nombre de composants
190
NASDAQ Biotechnology Total Retu Graphique des prix
Top 5 Gagnants au Cours des Dernières 24 Heures
| TBPH | Theravance Biopharma | +7.61% | |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics | +4.42% | |
| LIFE | aTyr Pharma | +4.35% | |
| RGLS | Regulus Therapeutics | +4.13% | |
| GERN | Geron | +3.43% |
Top 5 Perdants au Cours des Dernières 24 Heures
| PACB | Pacific Biosciences of California | -9.09% | |
|---|---|---|---|
| ESPR | Esperion Therapeutics | -7.36% | |
| TRVN | Trevena | -7.31% | |
| SAGE | Sage Therapeutics | -6.82% | |
| DRRX | DURECT | -6.62% |
NASDAQ Biotechnology Total Retu XNBI APERÇU FINANCIER ET COMMERCIAL
| NASDAQ Biotechnology Total Retu Prix de l'Indice | 4501.69 USD |
| Dernière clôture | 4472.96 USD |
| Ouverture | 4476.26 USD |
| Offre | 0 USD x 0 |
| Demande | 0 USD x 0 |
| Variation du jour | 4464.53 - 4532.84 USD |
| Plage sur 52 semaines | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume moyen | N/A |
Informations de trading
NASDAQ Biotechnology Total Retu Historique des prix de l'Indice
| Plus haut sur 52 semaines | 4532.84 USD |
| Plus bas sur 52 semaines | 4464.53 USD |
| Moyenne mobile sur 50 jours | N/A |
| Moyenne mobile sur 200 jours | N/A |
XNBI Statistiques de l'indice
| Volume moyen (3 mois) | N/A |
| Volume journalier moyen (10 jours) | N/A |
Questions et réponses concernant l'indice NASDAQ Biotechnology Total Retu
Quel est le cours actuel de l'Indice XNBI ?
Le prix de l'Indice NASDAQ Biotechnology Total Retu XNBI aujourd'hui est de 4501.69 USD.
Comment acheter l'Indice NASDAQ Biotechnology Total Retu ?
Vous pouvez acheter l'indice XNBI sur la plateforme Nasdaq GIDS. Contactez votre conseiller financier pour choisir un courtier.
Quel est le symbole boursier de l'Indice NASDAQ Biotechnology Total Retu ?
Le symbole boursier ou ticker de l'Indice NASDAQ Biotechnology Total Retu est XNBI.
Combien de composants contient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu contient 190 composants.
À quel pays appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à United States.
À quelle bourse appartient l'Indice NASDAQ Biotechnology Total Retu ?
L'Indice NASDAQ Biotechnology Total Retu fait référence à la bourse Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPOSANTS
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $299.62 — |
-0.23
|
$143.24B — | $2.8M — | $266.17 — | $269.3 — | $143.24B — | 21.41 | $12.48 — |
| Vertex Pharmaceuticals Incorporated VRTX | $402.19 — |
-0.67
|
$102.49B — | $161.92K — | $393.76 — | $400.14 — | $102.49B — | 28.56 | $13.88 — |
| Regeneron Pharmaceuticals REGN | $956.84 — |
-0.02
|
$99.3B — | $55.31K — | $898.26 — | $912.22 — | $99.3B — | 26.04 | $34.74 — |
| Gilead Sciences GILD | $64.79 — |
+0.02
|
$84.88B — | $582.89K — | $67.62 — | $68.48 — | $84.88B — | 15.12 | $4.5 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Biogen BIIB | $194.42 — |
-0.38
|
$28.81B — | $140.43K — | $197.79 — | $205.24 — | $28.81B — | 24.86 | $7.97 — |
| Illumina ILMN | $117.5 — |
-0.67
|
$20.24B — | $1.63M — | $126.44 — | $134.85 — | $20.24B — | 0 | -$7.35 — |
| Alnylam Pharmaceuticals ALNY | $144.63 — |
-0.99
|
$18.78B — | $90.25K — | $148.28 — | $151.8 — | $18.78B — | 0 | -$3.52 — |
| BioMarin Pharmaceutical BMRN | $83 — |
+1.1
|
$17.5B — | $147.41K — | $91.09 — | $93.26 — | $17.5B — | 106.00 | $0.87 — |
| Neurocrine Biosciences NBIX | $134.66 — |
-0.93
|
$13.54B — | $577.34K — | $134.63 — | $137.78 — | $13.54B — | 54.73 | $2.46 — |
| Incyte INCY | $51.34 — |
-0.61
|
$12.09B — | $123.1K — | $53.76 — | $55 — | $12.09B — | 20.32 | $2.65 — |
| Sarepta Therapeutics SRPT | $130.81 — |
+1.58
|
$11.53B — | $121.22K — | $121.49 — | $124.82 — | $11.53B — | 0 | -$5.8 — |
| United Therapeutics UTHR | $239.27 — |
+2.05
|
$10.95B — | $71.37K — | $232.41 — | $239.32 — | $10.95B — | 11.73 | $19.82 — |
| Bio-Techne TECH | $63.5 — |
-0.3
|
$10.49B — | $101.59K — | $66.29 — | $68.52 — | $10.49B — | 48.00 | $1.39 — |
| Repligen RGEN | $171.53 — |
-2.58
|
$9.58B — | $706.4K — | $169.74 — | $174.62 — | $9.58B — | 231.79 | $0.74 — |
- {{ link.label }} {{link}}